186 related articles for article (PubMed ID: 24928034)
21. Kaposi's sarcoma-associated herpesvirus vIRF2 protein utilizes an IFN-dependent pathway to regulate viral early gene expression.
Koch S; Damas M; Freise A; Hage E; Dhingra A; Rückert J; Gallo A; Kremmer E; Tegge W; Brönstrup M; Brune W; Schulz TF
PLoS Pathog; 2019 May; 15(5):e1007743. PubMed ID: 31059555
[TBL] [Abstract][Full Text] [Related]
22. IRF4 promotes Epstein-Barr virus activation in Burkitt's lymphoma cells.
Gao Y; Wang L; Lei Z; Li J; Forrest JC; Liang X
J Gen Virol; 2019 May; 100(5):851-862. PubMed ID: 30907723
[TBL] [Abstract][Full Text] [Related]
23. Deregulation of KSHV latency conformation by ER-stress and caspase-dependent RAD21-cleavage.
De Leo A; Chen HS; Hu CC; Lieberman PM
PLoS Pathog; 2017 Aug; 13(8):e1006596. PubMed ID: 28854249
[TBL] [Abstract][Full Text] [Related]
24. Kaposi's sarcoma-associated herpesvirus-induced angiogenin plays roles in latency via the phospholipase C gamma pathway: blocking angiogenin inhibits latent gene expression and induces the lytic cycle.
Sadagopan S; Valiya Veettil M; Paudel N; Bottero V; Chandran B
J Virol; 2011 Mar; 85(6):2666-85. PubMed ID: 21209106
[TBL] [Abstract][Full Text] [Related]
25. FUS Negatively Regulates Kaposi's Sarcoma-Associated Herpesvirus Gene Expression.
Dunker W; Song Y; Zhao Y; Karijolich J
Viruses; 2018 Jul; 10(7):. PubMed ID: 29986386
[TBL] [Abstract][Full Text] [Related]
26. Epigenetic regulation of Kaposi's sarcoma-associated herpesvirus replication.
Pantry SN; Medveczky PG
Semin Cancer Biol; 2009 Jun; 19(3):153-7. PubMed ID: 19429478
[TBL] [Abstract][Full Text] [Related]
27. Identification of new antiviral agents against Kaposi's sarcoma-associated herpesvirus (KSHV) by high-throughput drug screening reveals the role of histamine-related signaling in promoting viral lytic reactivation.
Chen J; Dai L; Goldstein A; Zhang H; Tang W; Forrest JC; Post SR; Chen X; Qin Z
PLoS Pathog; 2019 Dec; 15(12):e1008156. PubMed ID: 31790497
[TBL] [Abstract][Full Text] [Related]
28. Cdk1 inhibition induces mutually inhibitory apoptosis and reactivation of Kaposi's sarcoma-associated herpesvirus.
Li X; Chen S; Sun R
J Virol; 2012 Jun; 86(12):6668-76. PubMed ID: 22496227
[TBL] [Abstract][Full Text] [Related]
29. Transcriptional downregulation of ORF50/Rta by methotrexate inhibits the switch of Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 from latency to lytic replication.
Curreli F; Cerimele F; Muralidhar S; Rosenthal LJ; Cesarman E; Friedman-Kien AE; Flore O
J Virol; 2002 May; 76(10):5208-19. PubMed ID: 11967335
[TBL] [Abstract][Full Text] [Related]
30. In primary effusion lymphoma cells, MYB transcriptional repression is associated with v-FLIP expression during latent KSHV infection while both v-FLIP and v-GPCR become involved during the lytic cycle.
Lacoste V; Nicot C; Gessain A; Valensi F; Gabarre J; Matta H; Chaudhary PM; Mahieux R
Br J Haematol; 2007 Aug; 138(4):487-501. PubMed ID: 17659053
[TBL] [Abstract][Full Text] [Related]
31. Full-Length Isoforms of Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen Accumulate in the Cytoplasm of Cells Undergoing the Lytic Cycle of Replication.
Garrigues HJ; Howard K; Barcy S; Ikoma M; Moses AV; Deutsch GH; Wu D; Ueda K; Rose TM
J Virol; 2017 Dec; 91(24):. PubMed ID: 28978712
[TBL] [Abstract][Full Text] [Related]
32. Fine-Tuning of the Kaposi's Sarcoma-Associated Herpesvirus Life Cycle in Neighboring Cells through the RTA-JAG1-Notch Pathway.
Li S; Hu H; He Z; Liang D; Sun R; Lan K
PLoS Pathog; 2016 Oct; 12(10):e1005900. PubMed ID: 27760204
[TBL] [Abstract][Full Text] [Related]
33. Reactivation of Kaposi's sarcoma-associated herpesvirus from latency requires MEK/ERK, JNK and p38 multiple mitogen-activated protein kinase pathways.
Xie J; Ajibade AO; Ye F; Kuhne K; Gao SJ
Virology; 2008 Feb; 371(1):139-54. PubMed ID: 17964626
[TBL] [Abstract][Full Text] [Related]
34. Toll-like receptor signaling controls reactivation of KSHV from latency.
Gregory SM; West JA; Dillon PJ; Hilscher C; Dittmer DP; Damania B
Proc Natl Acad Sci U S A; 2009 Jul; 106(28):11725-30. PubMed ID: 19564611
[TBL] [Abstract][Full Text] [Related]
35. Kaposi sarcoma-associated herpesvirus degrades cellular Toll-interleukin-1 receptor domain-containing adaptor-inducing beta-interferon (TRIF).
Ahmad H; Gubbels R; Ehlers E; Meyer F; Waterbury T; Lin R; Zhang L
J Biol Chem; 2011 Mar; 286(10):7865-7872. PubMed ID: 21212282
[TBL] [Abstract][Full Text] [Related]
36. Effects of NFkappaB activation on KSHV latency and lytic reactivation are complex and context-dependent.
Grossmann C; Ganem D
Virology; 2008 May; 375(1):94-102. PubMed ID: 18321555
[TBL] [Abstract][Full Text] [Related]
37. Kaposi's Sarcoma-Associated Herpesvirus Viral Interferon Regulatory Factor 1 Interacts with a Member of the Interferon-Stimulated Gene 15 Pathway.
Jacobs SR; Stopford CM; West JA; Bennett CL; Giffin L; Damania B
J Virol; 2015 Nov; 89(22):11572-83. PubMed ID: 26355087
[TBL] [Abstract][Full Text] [Related]
38. Identification of Novel Kaposi's Sarcoma-Associated Herpesvirus Orf50 Transcripts: Discovery of New RTA Isoforms with Variable Transactivation Potential.
Wakeman BS; Izumiya Y; Speck SH
J Virol; 2017 Jan; 91(1):. PubMed ID: 27795414
[TBL] [Abstract][Full Text] [Related]
39. Convergence of Kaposi's sarcoma-associated herpesvirus reactivation with Epstein-Barr virus latency and cellular growth mediated by the notch signaling pathway in coinfected cells.
Spadavecchia S; Gonzalez-Lopez O; Carroll KD; Palmeri D; Lukac DM
J Virol; 2010 Oct; 84(20):10488-500. PubMed ID: 20686042
[TBL] [Abstract][Full Text] [Related]
40. Mutual inhibition between Kaposi's sarcoma-associated herpesvirus and Epstein-Barr virus lytic replication initiators in dually-infected primary effusion lymphoma.
Jiang Y; Xu D; Zhao Y; Zhang L
PLoS One; 2008 Feb; 3(2):e1569. PubMed ID: 18253508
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]